Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy

Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, ...
JSTOR Daily

A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells

Recent findings suggest that hypoxia of the tumor microenvironment contributes to immune escape from natural killer (NK) cell-mediated cytotoxicity. Heat shock protein 70 (Hsp70) and the ...
The University of Manchester

Scientists develop stronger, longer-lasting perovskite solar cells

Scientists have found a way to make perovskite solar cells not only highly efficient but also remarkably stable, addressing one of the main challenges holding the technology back from widespread ...
News Medical

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

In a recent review published in Cell Biochemistry and Function, researchers assessed the association between natural killer (NK) cell dysfunction and coronavirus disease 2019 (COVID-19) disease ...
Pharmabiz

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy: Berlin, Germany Friday, January 9, 2026, 09:00 Hrs [IST] Bayer a ...